160

Diabetes & Endocrinology
Focuses on the endocrine system.
Sub Categories on Diabetes & Endocrinology
Latest Articles
Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study

Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study

by Elana GotkineFor patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according

Tirzepatide yields sustained weight reduction in obesity and prediabetes, finds study

by Elana GotkineFor patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reduction and a reduced risk for progression to type 2 diabetes, according
Large-scale study reveals new genetic details of diabetes

Large-scale study reveals new genetic details of diabetes

by Wynne Parry,Cornell UniversityGraphical Abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/jNaNet.2023.09.013In experiments of unprecedented scale, investigators at Weill Cornel

Large-scale study reveals new genetic details of diabetes

by Wynne Parry,Cornell UniversityGraphical Abstract. Credit:Cell Metabolism(2023). DOI: 10.1016/jNaNet.2023.09.013In experiments of unprecedented scale, investigators at Weill Cornel
The ability to chew properly may improve blood sugar levels in patients with type 2 diabetes

The ability to chew properly may improve blood sugar levels in patients with type 2 diabetes

by Mary Durlak,University at BuffaloPost-operative panoramic X-ray; fixed implant-supported restoration. Credit: University at BuffaloIf you're a health care provider treating people with ty

The ability to chew properly may improve blood sugar levels in patients with type 2 diabetes

by Mary Durlak,University at BuffaloPost-operative panoramic X-ray; fixed implant-supported restoration. Credit: University at BuffaloIf you're a health care provider treating people with ty
Wegovy: Why half of those taking it stop within a year, and what happens when they do

Wegovy: Why half of those taking it stop within a year, and what happens when they do

by Adam Collins and Martin Whyte,The ConversationCredit: Pixabay/CC0 Public DomainDespite the effectiveness of the newer generation of anti-obesity drugs—called GLP-1 receptor agonists—few can t

Wegovy: Why half of those taking it stop within a year, and what happens when they do

by Adam Collins and Martin Whyte,The ConversationCredit: Pixabay/CC0 Public DomainDespite the effectiveness of the newer generation of anti-obesity drugs—called GLP-1 receptor agonists—few can t
Fatigue? Unexplained weight gain and dry skin? Could it be Hashimoto's disease?

Fatigue? Unexplained weight gain and dry skin? Could it be Hashimoto's disease?

by Aakansha Zala,The ConversationHashimoto’s thyroiditis under the microscope. Antibodies against thyroid peroxidase and thyroglobulin were elevated. Credit:Patho/Wikimedia Commons,C

Fatigue? Unexplained weight gain and dry skin? Could it be Hashimoto's disease?

by Aakansha Zala,The ConversationHashimoto’s thyroiditis under the microscope. Antibodies against thyroid peroxidase and thyroglobulin were elevated. Credit:Patho/Wikimedia Commons,C
Protein-rich breakfasts found to boost satiety and concentration

Protein-rich breakfasts found to boost satiety and concentration

by Aarhus UniversityRatings of sensations in visual analog scales (VAS), and corresponding areas under the curve (AUC), for satiety (A & B), fullness (C & D), satisfaction (E & F), hu

Protein-rich breakfasts found to boost satiety and concentration

by Aarhus UniversityRatings of sensations in visual analog scales (VAS), and corresponding areas under the curve (AUC), for satiety (A & B), fullness (C & D), satisfaction (E & F), hu
SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe